The Basic Non-Invasive Prenatal Test (NIPT)  is a screening blood test performed after 10 weeks of pregnancy. It analyses the baby’s DNA in the mother’s blood, providing a highly accurate assessment of the risk for genetic conditions like Down syndrome, Trisomy 18 and Trisomy 13. NIPT carries no risk to the baby and also offers the option to determine the baby’s gender.

The Advance Non-Invasive Prenatal Test (NIPT) is a more comprehensive version of the standard NIPT test. It is a screening blood test performed after 10 weeks of pregnancy, analysing the baby’s DNA in the mother’s blood. This test provides a highly accurate assessment of the risk for genetic conditions like Down syndrome, Trisomy 18 and Trisomy 13, as well as sex chromosome anomalies such as Turner’s Syndrome (X0), Klinefelter’s Syndrome (XXY), Jacob’s Syndrome (XYY) and Triple X Syndrome (XXX). NIPT carries no risk to the baby and also offers the option to determine the baby’s gender.

The Early Gender Test analyzes fetal DNA in the expectant mother's blood sample to determine the baby's gender. By detecting the presence of Y chromosomes, the test identifies a male fetus (XY chromosomes) or a female fetus (XX chromosomes). This test provides an accurate and non-invasive method to reveal the baby's gender early in the pregnancy.